Faga Daniel 4

What Happened
Daniel Faga — President, CEO and a director of ANAPTYSBIO, Inc. (ANAB) — was reported as receiving 34,300 performance-based restricted stock units (PSUs) that vested/was certified on March 25, 2026. Following the vesting/settlement, Faga sold 17,679 shares in multiple open-market transactions on March 27, 2026, generating approximately $1,089,199. The sales were reported as "sell to cover" transactions to satisfy tax-withholding obligations related to the PSU settlement (i.e., not discretionary sell orders).

Key Details

• Transaction dates: Award/vesting on 2026-03-25; shares sold on 2026-03-27; Form 4 filed 2026-03-27 (appears timely).
• Award: 34,300 PSUs earned per performance certification (each PSU = one share).
• Sales: 17,679 shares disposed across multiple lots, total proceeds ≈ $1,089,199. Individual reported sale prices ranged roughly from $56.29 to $65.99 per share (several lots reported as weighted-average prices with narrower ranges).
• Reason: Sales were to cover tax withholding on PSU vesting (sell-to-cover), and the filing notes these were not discretionary transactions.
• Shares owned after transaction: not specified in the provided summary — see the full Form 4 for total beneficial ownership.
• Footnotes: Filing includes weighted-average price groupings and offers to provide per-price breakdowns on request (see footnotes in the Form 4).

Context
This filing shows a standard post-vesting "sell to cover" where an insider receives performance shares and sells a portion to satisfy tax obligations. Such transactions generally reflect tax logistics rather than a direct signal of confidence or lack thereof. For full details (exact ownership after the transactions and the per-price breakdowns for each lot), consult the filed Form 4 (Accession No. 0001673528-26-000007).